Contents & References of Investigation of the effect of levothyroxine treatment on serum lipids in patients with mild hypothyroidism
List:
Chapter One: Introduction to Research.1
1-1 Statement of the Problem: 2
1-2 Research Objectives.5
1-3 Research Questions and Assumptions.6
Chapter Two: Knowledge Available in Research.7
1-2 Part One: Conceptual Framework.8
2-1-1 Gland Thyroid. 8.
2-1-2 Hypothyroidism. 17
2-1-3 Dyslipidemia. 28
2-2 Part Two: Review of the studies done. Sixth: conclusions and suggestions. 75
Resources..76
Source:
Dan. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, et al. Harrison's Principles of Internal Medicine. 18th ed. Tehran: Andishe Rafi; 1388. p. 477-499. [Text in Persian]
Michael T. McDermott. E. Chester Ridgway. subclinical hypothyroidism is mild thyroid failure and should be treated. The journal of clinical endocrinology & metabolism. 2001;32:123.
Charles j.Glueck.Cholesterol. center jewish hospital.
4. B.A. ryff.De leche.Jestaube.et al. LDL/HDL-change in subclinical hypothyroidism: possible risk factors for coronary heart disease. Department of internal medicine, university hospital of Basel ch-4031. [serialonline].
5. Teixeria PFS. Reuters VS. Ferreira MM. et al. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Department de medicina intera. Hospital de terrassa. [serialonline].
6. Wiseman SA, Powell JT, Humphries SE, Press M. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene. J Clin Endocrinol Metab. 1993 Jul;77(1):108
7. Shlomo Melmed, Kenneth S. Polonsky, MD, P. Reed MD Larsen and Henry M. Kronenberg. Williams text book of endocrinology. 12th edition. Chapter 12.893-7
8. Baliant Kacsoh. Endocrine physiology. first ed. Mc Graw - Hill. 2008. p. 202-213
9. Ganoge W.F.Review of medical physiology.2 ed.Parentic-Hall.2004.p.1677-79
10. Moradi sedighe, Hedaiati Mahdi, Azizi fereidun. Effect of LT4 treatment on clinical and laboratory findings in subclinical hypothyroidism patients. Iran`s endocrine and metabolism magazine. 2004;1:27-28
11. Shahbazian Hajie, Mohammadi Somaye, et al. Effect of 6 months L-thyroxin therapy on lipid profile of subclinical hypothyroidism. Department of endocrinology Ahvaz. 2009;87:22
12. Razavi s. Ingoe L. Keeka G. the beneficial effect of L-thyroxin on cardiovascular risk factors. endothelial function. and quality of life in subclinical hypothyroidism. the journal of Queen Elizabeth Hospital, United Kingdom. 2009 October; 24:145
13. Tunbridge WM, Evered DC, Hall R, Bird T, Evans JG, French JM, Young E. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7:481– 493
14. Sawin CT, Chopra D, Azizi F, Mannix JE, Bacharach P 1979 The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA. 242:247–250
15. Ineck BA, Ng TM. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother. 2003 May;37(5):725-30.
16.Bastenie PA, Vanhaelst L, Neve P. Coronary-artery disease in hypothyroidism. Lancet. 1967 Dec 9;2(7528):1221-2.
17. Fowler PS, Swale J. Premyxoedema and coronary-artery disease. Lancet. 1967 May 20;1(7499):1077-9.
18. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2004 May;89(5):2099-106.
19. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R, Müller B. TSH-controlled L-thyroxine therapy reducesTSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001 Oct;86(10):4860-6.
20. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Troms? Study. J Intern Med. 2006 Jul;260(1):53-61
21. Pazos F, Alvarez jj, Rubies-part j, et all. Long term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J clin endocrine metab 1995;80:562.
22. Ito M, Arishima T, Kudo T, et al. Effect of levo-thyroxin replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinal metab 2007;92:608
23. de Brulin TW, Van barlingen H, Van Linde-sibenius Trip M. et all. Lipoprotein (a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J clin endocrinal metab 1993;76:121.
24. Martinez-Triguero ML, Hernandez-Mijares A, Nguyen TT, et al. Effect of thyroid hormone replacement on lipoprotein(a). lipid and apolipoprotein in subjects with hypothyroidism. Myo Clin proc 1998;73:837
25. Gilbert A. Geraldo Medeiros-neto, Juliana C Vinagre, et al. Lipid metabolism in subclinical hypothyroidism. 2011;21:4
26. Efstathiadou Z, Bitsis S, Milionis HJ, et al. lipid profile in subclinical hypothyroidism. Eur J Endocrinol 2001;145:705-10
27. Ross DS 2000 Subclinical hypothyroidism. In: Braverman LE, Utiger RU, eds. Werner and Ingbar's the thyroid, 8th Ed. New York: Lippincott-Williams & Wilkins; 1001–1006
28. Ito M, Takamatsu J, Masuo T, et al. Serum concentration of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinal (oxf)2003;58:621
29. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008:29:76
30. Surk MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J clin Endocrinol metab 2007:92:4575.
31. Mc Dermott MT, Ridgway EC, subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol metab 2001:86:4585.
32. Gharib H, Tuttle RM, Baskin HJ, et al. subclinical thyroid dysfunction: a joint statement on management from the American association of clinical endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005:90:581.
33. Cooper DS, Halpren R, Wood LC, Levin AA, Ridgway EC. L-Thyroxin therapy in subclinical hypothyroidism. Ann intern med1984;101:18-24
34. Bemben DA, Winn P, Hamm RM, Morgan L et al. Thyroid disease in the elderly. part 1. prevalence of undiagnosed hypothyroidism. J Fam Pract 1994;38:577-82
35. Serter R. Demirbas B, Cakal E, Aral Y. The effect of L-thyroxin replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 2004;27(10):897-903
36. Keventy J, Heldgaard PE, Gram J et al. Subclinical hypothyroidism is associated with low-grade inflammation, increased triglyceride level and predicts cardiovascular disease. Clin Endocrinol(oxf) 2004;61(2):223-8
37. Haggerty JJ Jr, Evans DL, Prange A et al. Organic brain syndrome associated with marginal hypothyroidism. AMJ psychologyn1986;143:785-6
38. Friedwald WT, Levy RI. Estimation of the concentration of low-density lipoprotein cholesterol in plasma.